Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Ophthalmology

• Publication date

  2017-01-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjophthalmol-2016-309729PMID 28108569PMCID PMC5869687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-Related Macular Degeneration and Smoking

  2017cited by this paper
• Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study.

  2015cited by this paper
• Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?

  2015cited by this paper
• Evaluation of real-world mobility in age-related macular degeneration

  2015cited by this paper
• Harmonizing the Classification of Age-related Macular Degeneration in the Three-Continent AMD Consortium

  2014cited by this paper
• Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortium.

  2014cited by this paper
• Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations.

  2014cited by this paper
• Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

  2013cited by this paper
• Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium.

  2013cited by this paper
• Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.

  2011cited by this paper
• Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration.

  2010cited by this paper
• Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort.

  2008cited by this paper
• Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.

  2007cited by this paper
• Vision-related quality of life in patients with bilateral severe age-related macular degeneration.

  2005cited by this paper
• Global data on visual impairment in the year 2002.

  2004cited by this paper
• Cholesterol and age-related macular degeneration: is there a link?

  2004cited by this paper
• Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.

  2003cited by this paper
• The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.

  2003cited by this paper
• Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study.

  2002cited by this paper
• Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study.

  2002cited by this paper
• Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

  2002cited by this paper
• Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

  2001cited by this paper
• The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

  1997cited by this paper
• Age-related macular degeneration and smoking. The Rotterdam Study.

  1996cited by this paper
• Age-related macular degeneration and smoking. The Rotterdam Study.

  1996cited by this paper
• Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

  1995cited by this paper
• Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.

  1993cited by this paper
• Prevalence of age-related maculopathy. The Beaver Dam Eye Study.

  1992cited by this paper
• The Wisconsin age-related maculopathy grading system.

  1991cited by this paper

• Advancements in age-related macular degeneration treatment: From traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology.

  2025cites this paper
• Simultaneous bilateral intravitreal anti-vascular endothelial growth factor injections from one vial for diabetic macular edema: a retrospective analysis

  2025cites this paper
• Advancing AMD screening with an offline, AI-powered smartphone-based fundus camera: A prospective, real-world clinical validation

  2025cites this paper
• Safety Evaluation of Bilateral Same-Day Intravitreal Injection of Faricimab

  2025cites this paper
• Expanding Application of Optical Coherence Tomography Beyond the Clinic: A Narrative Review

  2025cites this paper
• Early Choriocapillaris Dysfunction in Fellow Eyes of Patients with Unilateral Neovascular Age-Related Macular Degeneration

  2024cites this paper
• MEASURED - REAL VALUES OF INTRAOCULAR TENSION, 24 H AFTER THE APPLICATION OF BROLUCIZUMAB INTRAVITREAL INJECTION IN PATIENTS WITH wAMD

  2024cites this paper
• Age-Related Macular Degeneration and Its Genetic Risk: A Population-based Study

  2024cites this paper
• Recent daily life burdens associated with neovascular age-related macular degeneration involve difficulties in use of electronic devices

  2024cites this paper
• Recent Advances in Our Understanding of Age-Related Macular Degeneration: Mitochondrial Dysfunction, Redox Signaling, and the Complement System

  2024cites this paper
• Age-Related RPE changes in Wildtype C57BL/6J Mice between 2 and 32 Months

  2024cites this paper
• Bilateral Involvement of Age-Related Macular Degeneration in South Korea: Findings from the Korea National Health and Nutrition Examination Survey 2017–2020

  2024cites this paper
• Eye dominance and testing order effects in the circularly-oriented macular pigment optical density measurements that rely on the perception of structured light-based stimuli

  2024cites this paper
• Associations Between Contrast Sensitivity, OCT Features and Progression from Intermediate to Late Age-related Macular Degeneration.

  2024cites this paper
• Reply

  2024cites this paper
• Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

  2023cites this paper
• VITAMIN D LEVEL AND ITS LINK WITH VISUAL ACUITY AND CONTRAST SENSITIVITY IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION.

  2023cites this paper
• Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration

  2023cites this paper
• Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study

  2023cites this paper
• Relative Telomere Length Is Associated with the Risk of Development and Severity of the Course of Age-Related Macular Degeneration in the Russian Population

  2023cites this paper
• Choroidal Features of Healthy Iranian Individuals

  2023cites this paper
• FIVE-YEAR INCIDENCE OF FELLOW EYE NEOVASCULAR INVOLVEMENT IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY IN AN ASIAN POPULATION

  2023cites this paper
• Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor

  2023cites this paper
• What about the fellow eye in treatment of neovascular age‐related macular degeneration? Analysis of data from the Swedish macula register

  2022cites this paper
• Imaging characteristics of bilateral CSCR cases:12 months follow up

  2022cites this paper
• Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.

  2022cites this paper
• Linking Function and Structure with ReSenseNet: Predicting Retinal Sensitivity from Optical Coherence Tomography using Deep Learning.

  2022cites this paper
• Progression of age-related macular degeneration in eyes with abnormal fundus autofluorescence in a Japanese population: JFAM study report 3

  2022cites this paper
• N-Glycosylation Patterns across the Age-Related Macular Degeneration Spectrum

  2022cites this paper
• CCL2, CCR2 Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration

  2022cites this paper
• [Value of systematic screening for depressive symptoms and Charles-Bonnet syndrome in AMD patients].

  2022cites this paper
• Prevalence and risk factors for age-related macular degeneration in a population-based cohort study of older adults in Northern Ireland using multimodal imaging: NICOLA Study

  2022cites this paper
• CPD: Age-related macular degeneration 1: Epidemiology and risk factors

  2022cites this paper
• Interocular asymmetry of choroidal thickness and vascularity index measurements in normal eyes assessed by swept-source optical coherence tomography.

  2021cites this paper
• Real-life-Ergebnisse der Anti-VEGF-Therapie bei nAMD der Partneraugen

  2021cites this paper
• Prevalence of Vitreoretinal Interface Disorders in an Australian Population

  2021cites this paper
• Macular neovascularization in eyes with pachydrusen

  2021cites this paper
• CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2020cites this paper
• Revisiting the role of factor H in age-related macular degeneration: insights from complement-mediated renal disease and rare genetic variants.

  2020cites this paper
• Morphological predictors and temporal characteristics of conversion from nonexudative to exudative Age related macular Degeneration in the fellow eye.

  2020cites this paper
• FIVE-YEAR INCIDENCE AND VISUAL ACUITY OUTCOMES FOR INTRAVITREAL THERAPY IN BILATERAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fight Retinal Blindness! Project.

  2020cites this paper
• Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study

  2020cites this paper
• The Diagnosis and Treatment of Age-Related Macular Degeneration.

  2020cites this paper
• The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration.

  2019cites this paper
• Characterization of Patients With Geographic Atrophy in Routine Clinical Practice.

  2019cites this paper
• Degenerescência macular relacionada com a idade

  2019cites this paper
• Retinal Pathologic Features on OCT among Eyes of Older Adults Judged Healthy by Color Fundus Photography.

  2019cites this paper
• Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration

  2019cites this paper
• Subretinal drusenoid deposits AKA pseudodrusen.

  2018cites this paper
• Genome-wide analysis of disease progression in age-related macular degeneration

  2018cites this paper
• Adenosine A1 receptor: A neuroprotective target in light induced retinal degeneration

  2018cites this paper
• The Rotterdam Study: 2018 update on objectives, design and main results

  2017cites this paper
• Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases

  year unknowncites this paper